Oncologic impact of preoperative prognostic nutritional index change in resected pancreatic cancer following neoadjuvant chemotherapy

Siegel, 2018, Cancer statistics, CA A Cancer J Clin, 68, 7, 10.3322/caac.21442 Vincent, 2011, Pancreatic cancer, Lancet, 378, 607, 10.1016/S0140-6736(10)62307-0 Zhan, 2017, Neoadjuvant therapy in pancreatic cancer: a systematic review and meta- analysis of prospective studies, Cancer Med, 6, 1201, 10.1002/cam4.1071 Versteijine, 2018, Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer, Br J Surg, 105, 946, 10.1002/bjs.10870 Katz, 2008, Borderline resectable pancreatic cancer: the importance of this emerging stage of disease, J Am Coll Surg, 206, 833, 10.1016/j.jamcollsurg.2007.12.020 Lind, 2008, Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma, Acta Oncol, 47, 413, 10.1080/02841860701592384 Jang, 2018, Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial, Ann Surg, 268, 215, 10.1097/SLA.0000000000002705 Cid-Arregui, 2015, Perspectives in the treatment of pancreatic adenocarcinoma, World J Gastroenterol, 21, 9297, 10.3748/wjg.v21.i31.9297 Ozola Zalite, 2015, Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review, Pancreatology, 15, 19, 10.1016/j.pan.2014.11.006 Davidson, 2004, Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer, Clin Nutr, 23, 239, 10.1016/j.clnu.2003.07.001 Amedei, 2014, Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy, Hum Vaccines Immunother, 10, 3354, 10.4161/hv.34392 Andreyev, 1998, Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?, Eur J Cancer, 34, 503, 10.1016/S0959-8049(97)10090-9 Braga, 2002, Nutritional approach in malnourished surgical patients, Arch Surg, 137, 174, 10.1001/archsurg.137.2.174 Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 Stevens, 2015, Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review, HPB, 17, 285, 10.1111/hpb.12355 Geng, 2015, Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer, Eur J Surg Oncol, 41, 1508, 10.1016/j.ejso.2015.07.022 Yamada, 2016, Clinical implication of inflammation-based prognostic score in pancreatic cancer: Glasgow prognostic score is the most reliable parameter, Medicine, 95, 10.1097/MD.0000000000003582 Migita, 2013, The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage, Ann Surg Oncol, 20, 2647, 10.1245/s10434-013-2926-5 Feng, 2014, Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma, Ther Clin Risk Manag, 10, 1 Mohri, 2013, Prognostic nutritional index predicts postoperative outcome in colorectal cancer, World J Surg, 37, 2688, 10.1007/s00268-013-2156-9 Kanda, 2011, Nutritional predictors of postoperative outcome in pancreatic cancer, Br J Surg, 98, 268, 10.1002/bjs.7305 Lee, 2017, The significance of the prognostic nutritional index for all stages of pancreatic cancer, Nutr Cancer, 69, 512, 10.1080/01635581.2016.1250921 Onodera, 1984, Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients, Nihon Geka Gakkai Zasshi, 85, 1001 Ikeguchi, 2017, C-reactive protein/albumin ratio and prognostic nutritional index are strong prognostic indicators of survival in resected pancreatic ductal adenocarcinoma, J Pancreat Cancer, 3, 31 Gillen, 2010, Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages, PLoS Med, 7, 10.1371/journal.pmed.1000267 Satoi, 2009, Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer, Pancreas, 38, 282, 10.1097/MPA.0b013e31819438c3 Heinrich, 2017, Neoadjuvant therapy of pancreatic cancer: definitions and benefits, Int J Mol Sci, 18, 1622, 10.3390/ijms18081622 Steyn, 1995, Weight gain as an indicator of response to chemotherapy for oesophageal carcinoma, Clin Oncol (R Coll Radiol)., 7, 382, 10.1016/S0936-6555(05)80010-X Migita, 2017, A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients, Surg Today, 47, 1018, 10.1007/s00595-017-1469-y Heinrich, 2008, Prospective phase II trial on neoadjuvant chemotherapy with Gemcitabine and Cisplatin for resectable adenocarcinoma of the pancreatic head, J Clin Oncol, 26, 2526, 10.1200/JCO.2007.15.5556 Naumann, 2013, Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer, Strahlenther Onkol, 189, 745, 10.1007/s00066-013-0393-3 Sho, 2013, Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer, J Hepatobiliary Pancreat Sci, 20, 197, 10.1007/s00534-012-0532-8 Tashiro, 2018, Clinical impact of neoadjuvant therapy on nutritional status in pancreatic cancer, Ann Surg Oncol, 25, 3365, 10.1245/s10434-018-6699-8 Choi, 2019, Rates of serious complications estimated by the ACS-NSQIP surgical risk calculator in predicting oncologic outcomes of patients treated with pancreaticoduodenectomy for pancreatic head cancer, J Gastrointest Surg, 23, 1180, 10.1007/s11605-018-4041-1